Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.12 (
PKG
)
2,515
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The large number of covalently bound phosphates on the extracellular phosphoproteins osteopontin (OPN) and
bone sialoprotein
(
BSP
) have been implicated in biological functions such as mineral deposition and osteoclast binding. In the present study the state of phosphorylation of
BSP
and OPN was evaluated by in vitro 32P labeling using a series of protein kinases and quantification. Both the purified bovine
BSP
and OPN were radiolabeled by [32P]ATP and factor-independent protein kinase. Quantification of 32P radioactivity incorporated on dephosphorylated
BSP
and OPN provided 6.6 and 8.9 mol of phosphate incorporated/mol, respectively. Native OPN incorporated 1.07 and
BSP
2.46 mol of phosphate/mol by factor-independent protein kinase. These data led to calculations that OPN and
BSP
, respectively, contain 7.83 and 4.14 mol of phosphate/mol in their natural state. Thrombin digests of 32P-labeled
BSP
showed radioactivity to be associated with fragment of approximately molecular mass values 30 kDa (N-terminal half), with no observable radioactivity associated with the 40-kDa fragment (C-terminal half). Similar experiments with 32P-labeled OPN provided two radiolabeled thrombin fragments, with molecular mass 30 kDa (N-terminal half) and 20 kDa (C-terminal half), both were radioactive. The major phosphorylation was associated with the N-terminal half containing 7.0 mol of phosphate, and 1.9 mol of phosphate were associated with the C-terminal half. Additional experiments of in vitro phosphorylation of OPN and
BSP
by several other known protein kinases were carried out. cAMP-dependent protein kinase showed no phosphorylation of OPN or
BSP
, while protein kinase C and
cGMP-dependent protein kinase
led to minor phosphorylation, each of the latter introduced about 1 mol of phosphate/mol of OPN and
BSP
molecule.
...
PMID:Phosphorylation of purified bovine bone sialoprotein and osteopontin by protein kinases. 866 67
Cytosolic and microsomal protein kinase preparations from cultured chicken osteoblasts were found to phosphorylate up to six major proteins with Mrs 66, 58, 50, 36, 32, and 22 kDa in chicken bone extract. Use of heparin led to the conclusion that these proteins were predominantly phosphorylated by factor-independent protein kinase (FIPK) present both in microsomal and cytosolic preparations. It was confirmed that microsomal preparation contained predominantly FIPK, whereas cytosolic preparation contained additional kinases, that can phosphorylate the bone proteins. Use of purified chicken bone osteopontin (OPN) (58 kDa) and recombinant OPN led to the same conclusions. The identify of the protein kinases was clearly established by using a series of synthetic peptide substrates. Quantitative analysis utilizing pure protein kinases and purified chicken bone OPN, recombinant mouse OPN, and bovine bone OPN and
BSP
led to introduction of approximately 9 moles of phosphate/mole of OPN and 6.6 moles phosphate/mole bovine
bone sialoprotein
(
BSP
) by casein kinase II.
cGMP-dependent protein kinase
and protein kinase C both introduced 0.5-1.2 moles phosphate/mole of OPN and
BSP
, whereas cAMP-dependent protein kinase led to no significant phosphorylation of OPN or
BSP
. Consistent with the above results, sites of phosphorylation identified for OPN (metabolically labeled) and
BSP
(labeled by casein kinase II) revealed that predominant phosphorylated sites have recognition sequences for FIPK.
...
PMID:Protein kinases of cultured chicken osteoblasts that phosphorylate extracellular bone proteins. 908 59